Methotrexate tablets are generic version of
This is the 9 th ANDA (including 1 tentative approval) to be approved out of Eugia formulation facility in
Methotrexate tablets are indicated in the treatment of
Gestational choriocarcinoma, chorio-adenoma destruens and hydatidiform mole
Used alone or in combination with other anticancer agents in the treatment of breast cancer, epidermoid cancers of the head and neck, advanced mycosis fungoides (cutaneous T cell lymphoma), and lung cancer, particularly squamous cell and small cell types
Symptomatic control of severe, recalcitrant, disabling psoriasis.
Selected adults with severe, active, rheumatoid arthritis (ACR criteria), or children with active polyarticular-course juvenile rheumatoid arthritis.
About
Contact:
Tel: 040-66725401
Email: ir@aurobindo.com
Disclaimer
This press release contain statements that may constitute 'forward looking statements' including and without limitation, statements relating to product characteristics and uses, sales potential and target dates for product launch , implementation of strategic initiatives, and other statements relating to our future business developments and economic performance. While these forward looking statements represent our judgment and future expectations concerning the development of our business, a number of risks, uncertainties and other factors could cause actual developments and results to differ materially from our expectations. The company undertakes no obligation to publicly revise any forward looking statements to reflect future events or circumstances and will not be held liable for any use of this information.
(C) 2020 Electronic News Publishing, source